An American Society of Plastic Surgeons report1 found Americans spent more than $16 billion on cosmetic plastic surgery and minimally invasive procedures in 2016. Several other sources provide similar estimates2.The world-wide market is at least twice this size3, with Brazil alone having more procedures than the US.

Cosmetic surgery procedures are growing rapidly3, with 1.7 million total US procedures per year, over 300,000 of which are eyelid/eyebrow procedures1. At the same time, minimally invasive procedures are growing even faster, and from a much larger base with 7 million neurotoxin (Botox) procedures, 2 million filler procedures, over a million chemical peels and over 600,000 laser treatments1.

It is important to note that surgical procedures are very effective at elevating/repositioning tissue, but with significant cost, morbidity and recovery time.

Conversely, neurotoxins, fillers, lasers and chemical peels are very effective at wrinkle treatment and tissue resurfacing at a modest cost and fast recovery time, but are not very effective at repositioning or elevating tissue.

The ZiftLift™ procedure target market includes patients for whom current minimally invasive treatments alone are not sufficient, but for whom the fear and/or cost of surgery prevents them from enjoying an optimal result. This is not intended as a replacement for neurotoxins, fillers or other treatments, but rather a complimentary treatment. By providing tissue elevation in a minimally invasive setting with fast recovery time, Zift Medical hopes to provide a new treatment option and “bridge-the-gap” between current minimally invasive treatments and surgery. 

Number of procedures and market opportunity for brow/forehead lifts.

1 American Society of Plastic Surgeons (2016). Plastic Surgery Statistics Report. Retrieved from
2 Stein, J. (2015, June) Nip, Tuck or Else. Time, 185(24).
3 PR Newswire, August 24, 2015.